Related Experiment Video
Updated: May 21, 2026

Pull-down of Calmodulin-binding Proteins
Published on: January 23, 2012
Protein flexibility is key to cisplatin crosslinking in calmodulin
Huilin Li1, Stephen A Wells, J Emilio Jimenez-Roldan
1Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom.
Cisplatin crosslinking of calmodulin (CaM) is possible due to its flexible structure, enabling Met residue side chains to approach. This flexibility analysis predicts and confirms CaM crosslinking, impacting protein target binding and potentially explaining tumor resistance to platinum drugs.
Area of Science:
- Proteomics
- Structural Biology
- Computational Biology
Background:
- Chemical crosslinking coupled with mass spectrometry is vital for protein structure and interaction studies.
- Cisplatin has been identified as a crosslinker for methionine residues in apo-calmodulin (apo-CaM), but experimental distances conflict with structural data.
Purpose of the Study:
- To investigate the mechanism of cisplatin crosslinking in calmodulin (CaM) despite apparent distance constraints.
- To explore the role of protein flexibility in facilitating crosslinking events.
- To assess the impact of cisplatin-induced crosslinking on CaM's functional interactions.
Main Methods:
- Fourier transform ion cyclotron resonance mass spectrometry (FTICR MS) for identifying crosslinked residues.
- Novel computational flexibility analysis to assess protein dynamics.
- In vitro binding assays comparing modified and unmodified CaM with melittin.
Main Results:
- Computational flexibility analysis revealed that CaM's dynamic motions allow methionine side chains to approach for cisplatin crosslinking in both apo-CaM and Ca₄-CaM.
- FTICR MS data confirmed cisplatin-mediated crosslinking in Ca₄-CaM.
- Cisplatin crosslinking was shown to inhibit CaM's binding to its target proteins, melittin.
Conclusions:
- Protein flexibility analysis is a valuable tool for predicting crosslinking sites and aiding mass spectrometry data interpretation.
- Cisplatin crosslinking of CaM interferes with its biological function by blocking target protein binding.
- These findings offer insights into platinum-based anticancer drug resistance mechanisms.
More Related Videos
12:19Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Cytoskeletal Accessory Proteins
Adaptability of Cytoskeletal Filaments
Intrinsically Disordered Proteins